Clinical Trial: Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

This study is currently recruiting patients.

Sponsored by:	National Institute on Drug Abuse (NIDA) University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Condition	Treatment or Intervention	Phase
Opioid-Related Disorders	Drug: Buprenorphine/naloxone	Phase III

MedlinePlus related topics: Drug Abuse

Study Type: Interventional
Study Design: Treatment, Uncontrolled

Official Title: Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents

Further Study Details:

Expected Total Enrollment: 183

Study start: March 2002

Eligibility

Ages Eligible for Study: 14 Years - 21 Years, Genders Eligible for Study: Both

Criteria

Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.

Location and Contact Information

Sabrina Poole (215)399-0980 Ext. 118 spoole@tresearch.org

Delaware
Brandywine Counseling Center, Wilmington, Delaware, 19805, United States; No longer recruiting

Maryland
Mountain Manor, Baltimore, Maryland, 21229, United States; Recruiting

Sabrina Poole 215-399-0980 Ext. 118 spoole@tresearch.org

New Mexico
ASAP, Albuquerque, New Mexico, 87106, United States; Recruiting

Sabrina Poole 215-399-0980 Ext. 118 spoole@tresearch.org

Ayudantes, Santa Fe, New Mexico, 87505, United States; Recruiting

Sabrina Poole 215-399-0980 Ext. 118 spoole@tresearch.org

North Carolina
Duke Addictions Program, Durham, North Carolina, 27710, United States; Recruiting

Sabrina Poole 215-399-0980 Ext. 118 spoole@tresearch.org

Study chairs or principal investigators

George Woody, M.D., Principal Investigator, University of Pennsylvania

More Information

Study ID Numbers: NIDA-CTN-0010-1
Record last reviewed: November 2004
Record first received: February 19, 2004
ClinicalTrials.gov Identifier: NCT00078130
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services